Form 8-K Karyopharm Therapeutics For: Apr 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
Karyopharm Therapeutics (KPTI) PT Raised to $21 at Wedbush
May 1, 2018 9:59 AM EDTWedbush raised its price target on Karyopharm Therapeutics (NASDAQ: KPTI) to $21.00 (from $19.00) while maintaining a Outperform rating.
Analyst David Nierengarten commented, "Topline results from STORM met our expectations and should be sufficient to support accelerated approval (AA) for selinexor plus dex in... More
